Cargando…
Metformin Dysregulates the Unfolded Protein Response and the WNT/β-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism
Multiple lines of evidence suggest that metformin, an antidiabetic drug, exerts anti-tumorigenic effects in different types of cancer. Metformin has been reported to affect cancer cells’ metabolism and proliferation mainly through the activation of AMP-activated protein kinase (AMPK). Here, we show...
Autores principales: | Conza, Domenico, Mirra, Paola, Calì, Gaetano, Insabato, Luigi, Fiory, Francesca, Beguinot, Francesco, Ulianich, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147131/ https://www.ncbi.nlm.nih.gov/pubmed/33946426 http://dx.doi.org/10.3390/cells10051067 |
Ejemplares similares
-
Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer
por: Conza, Domenico, et al.
Publicado: (2023) -
Endoplasmic Reticulum Stress in Endometrial Cancer
por: Ulianich, Luca, et al.
Publicado: (2014) -
The Pervasive Effects of ER Stress on a Typical Endocrine Cell: Dedifferentiation, Mesenchymal Shift and Antioxidant Response in the Thyrocyte
por: Ulianich, Luca, et al.
Publicado: (2020) -
Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
por: Pignalosa, Francesca Chiara, et al.
Publicado: (2021) -
PED/PEA-15 Inhibits Hydrogen Peroxide-Induced Apoptosis in Ins-1E Pancreatic Beta-Cells via PLD-1
por: Fiory, Francesca, et al.
Publicado: (2014)